Check out the companies making headlines yesterday:

Nubank (NYSE: NU): Digital banking platform Nubank (NYSE: NU) rose by 3.2% on Wednesday after the company revealed two new AI-powered financial models, attracting investor attention. See our full article here.

Is now the time to buy Nubank? Access our full analysis report here, it’s free.

Ocular Therapeutix (NASDAQ: OCUL): Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ: OCUL) rose by 7.2% on Wednesday after the company announced it reached an agreement with the U.S. Food and Drug Administration (FDA) on a plan to submit a New Drug Application (NDA) for its AXPAXLI injection. See our full article here.

Is now the time to buy Ocular Therapeutix? Access our full analysis report here, it’s free.

Mondelez (NASDAQ: MDLZ): Packaged snacks company Mondelez (NASDAQ: MDLZ) fell by 3% on Wednesday after the Federal Reserve held its benchmark rate at 3.5%–3.75% and delivered a dot plot pointing toward a potential hike See our full article here.

Is now the time to buy Mondelez? Access our full analysis report here, it’s free.

ResMed (NYSE: RMD): Medical device company ResMed (NYSE: RMD) fell by 4.5% on Wednesday after Morgan Stanley downgraded the stock to Equalweight from Overweight and lowered its price target. See our full article here.

Is now the time to buy ResMed? Access our full analysis report here, it’s free.

Sonos (NASDAQ: SONO): Audio technology Sonos company (NASDAQ: SONO) fell by 4.7% on Wednesday after investor concerns over new competition as Google unveiled its new Google Home Speaker. See our full article here.

Is now the time to buy Sonos? Access our full analysis report here, it’s free.